Gold Explorer Moves Higher on Drill Results

Enforcer Gold Corp. (TSXV:VEIN), a gold explorer, climbed after announcing results from its 2018 Phase 1 diamond drilling program on the MOP II gold-copper deposit

Sean Mason | June 20, 2018 | SmallCapPower

Assay results from Quebec caught the attention of a few gold explorer speculators Wednesday. Here’s some small stocks making big moves on Wednesday, June 20, 2018 (as of 4 pm EST):

Enforcer Gold Corp. (TSXV:VEIN) shares jumped 9% to $0.06 on Wednesday after the gold explorer announced results from its 2018 Phase 1 diamond drilling program on the MOP II gold-copper deposit in Quebec, which included 0.73 g/t gold over 219.7 metres.

Win Big With Our Small Cap Picks


As well, shares of iCo Therapeutics (TSXV:ICO) powered 106% higher to $0.165 as the biopharma company said it has completed the recruitment of all 32 subjects in the Company’s Phase 1 Oral Amphotericin B study, an approved drug for the treatment of fungal and parasitic conditions. The Company added that it currently expects results from the Phase 1 study in early July 2018.

Kraken Robotics Inc. (TSXV:PNG), meanwhile, reported that it has entered into a non-brokered private placement offering with Ocean Infinity Ltd., whereby Ocean Infinity will acquire 11,520,000 units at $0.20 per unit which, upon completion, will result in Ocean Infinity owning 9.99% of Kraken’s issued common shares. Kraken Robotics stock popped 33% to $0.20 following the announcement.

Finally, Pacton Gold Inc. (TSXV:PAC) shares rose 12% to $0.75 after the gold junior announced that it has entered into a binding letter of intent to acquire 100% of the Bellary Dome exploration license 47/2555 in the Pilbara region of Western Australia, located on the southern margin of the Hamersley Basin and surrounded by Novo Resources.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: